RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation (HYPOXEMIA) in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL).
View Complete Description-
Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
Authors: Junlan Zhang, Bao Luo, Liping Tang, Yongming Wang, Cecil R Stockard, Inga Kadish, Thomas Van Groen, William E Grizzle, Selvarangan Ponnazhagan, Michael B Fallon
Gastroenterology 2009 Mar -
Portopulmonary hypertension and hepatopulmonary syndrome.
Authors: Marius M Hoeper, Michael J Krowka, Christian P Strassburg
Lancet 2004 May 1
Thought leaders and organizations working on research involving hepatopulmonary syndrome.
- St. Michael's Hospital, Toronto
- Novartis
- University of Alabama at Birmingham
- Bristol-Myers Squibb
- University of Colorado at Denver and Health Sciences Center
- University of Alabama - Birmingham
- University of Vienna
- University of Alabama at Birmingham Liver Center
- Institute of Post Graduate Medical Education and Research
- Mayo Clinic College of Medicine
-
A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome
conditions: Hepatopulmonary Syndrome
interventions: Norfloxacin ; Placebo
-
Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome
conditions: Hepatopulmonary Syndrome
interventions: pentoxifylline
Community
-
No NextBio users were found for “hepatopulmonary syndrome”.
Complete your user profile with your interests, if you want others to find you within the NextBio community.
-
No NextBio groups were found for “hepatopulmonary syndrome”.
Be the first to start a group and share your interests with others within the NextBio community.
